MSF protest over EU India trade talk: Hands off our medicines
Millions of people in developing countries rely on affordable generic medicines to stay alive. More than 80% of the medicines used by Médecins Sans Frontières (MSF) to treat AIDS across the developing world are produced in India. But the European Commission is now shutting off the tap of affordable medicines by attacking the production, registration, transportation and exportation of generic medicines. People who need these will be left without a lifeline.
Médecins Sans Frontières invites everyone to send a message to the European Commission to keep their HANDS OFF OUR MEDICINE!
“To: Commissioner De Gucht, DG Trade
The European Commission is pushing trade policies and agreements that will greatly restrict access to affordable medicines for people in developing countries. If you continue to pursue your actions, people who rely on these medicines to stay alive will be left without a lifeline and many are likely to die.
I urge you therefore to take the following actions immediately:
• Stop pushing for provisions in free trade agreements that will turn off the tap on production of affordable generic medicines.
• Stop detaining generic medicines that are in transit through Europe on their way to patients in developing countries by amending the EC customs regulations now.
• Stop pushing for restrictions on production and supply of generic medicines through anti-counterfeiting policies like ACTA, the secretive international anti-counterfeiting trade agreement.
For those who desperately need these affordable, life-saving medicines all over the developing world, I ask that you reverse your positions and commit to supporting access to medicines for all.”
Externe Seite aufrufen